Cargando…
Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial
Autores principales: | Yamada, Hideto, Deguchi, Masashi, Saito, Shigeru, Takeshita, Toshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440280/ https://www.ncbi.nlm.nih.gov/pubmed/36065419 http://dx.doi.org/10.1016/j.eclinm.2022.101617 |
Ejemplares similares
-
Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial
por: Yamada, Hideto, et al.
Publicado: (2022) -
A High Dose Intravenous Immunoglobulin Therapy for Women with Four or More Recurrent Spontaneous Abortions
por: Yamada, Hideto, et al.
Publicado: (2012) -
Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses
por: Yamamoto, Haruko, et al.
Publicado: (2022) -
Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial
por: Miyasaka, Nobuyuki, et al.
Publicado: (2011) -
A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal
por: Rayamajhi, Ajit, et al.
Publicado: (2015)